Avantor (AVTR) Other Non-Current Assets (2018 - 2026)
Avantor (AVTR) recorded quarterly Other Non-Current Assets of $441.7 million in Q1 2026, up 11.54% quarter-over-quarter from $396.0 million in Q4 2025, and up 20.19% on a YoY basis from $367.5 million in Q1 2025.
Avantor (AVTR) Other Non-Current Assets (2018 - 2026) Analysis & Trends
Avantor's Other Non-Current Assets history runs 9 years deep, the most recent figure standing at $441.7 million for Q1 2026.
- In Q1 2026, Other Non-Current Assets rose 20.19% year-over-year to $441.7 million; the TTM figure through Mar 2026 stood at $441.7 million (up 20.19% YoY), while the FY2025 annual figure was $396.0 million, up 9.88% from the prior year.
- Other Non-Current Assets was $441.7 million for Q1 2026 at Avantor, up from $396.0 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $441.7 million in Q1 2026 to a low of $216.5 million in Q3 2024.
- Historically, Other Non-Current Assets has averaged $326.8 million across 5 years, with a median of $358.3 million in 2023.
- The sharpest annual moves came in 2024 and 2025: Other Non-Current Assets declined 25.14% in 2024, then jumped 87.39% in 2025.
- A 5-year view of Other Non-Current Assets shows it stood at $293.5 million in 2022, then gained by 22.08% to $358.3 million in 2023, then advanced by 0.59% to $360.4 million in 2024, then rose by 9.88% to $396.0 million in 2025, then gained by 11.54% to $441.7 million in 2026.
- The last three Other Non-Current Assets figures came in at $441.7 million (Q1 2026), $396.0 million (Q4 2025), and $405.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | - |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 2.43 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 446.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 210.73 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 81.30 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 848.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 672.80 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 39.83 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 692.00 Mn |
| 10 | Avantor | 6.47 Bn | 6.19 Bn | 500.70 Mn | 441.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 441.70 Mn |
| Dec 31, 2025 | 396.00 Mn |
| Sep 30, 2025 | 405.70 Mn |
| Jun 30, 2025 | 390.90 Mn |
| Mar 31, 2025 | 367.50 Mn |
| Dec 31, 2024 | 360.40 Mn |
| Sep 30, 2024 | 216.50 Mn |
| Jun 30, 2024 | 368.10 Mn |
| Mar 31, 2024 | 367.70 Mn |
| Dec 31, 2023 | 358.30 Mn |
| Sep 30, 2023 | 289.20 Mn |
| Jun 30, 2023 | 276.70 Mn |
| Mar 31, 2023 | 272.50 Mn |
| Dec 31, 2022 | 293.50 Mn |
| Sep 30, 2022 | 244.60 Mn |
| Jun 30, 2022 | 254.80 Mn |
| Mar 31, 2022 | 252.00 Mn |
| Dec 31, 2021 | 233.10 Mn |
| Sep 30, 2021 | 240.00 Mn |
| Jun 30, 2021 | 244.60 Mn |